Osteoporosis

Risk assessment and management of osteoporosis.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)

Last reviewed: 21 October 2025

Clinical Guidelines

European guidance for the diagnosis and management of osteoporosis

NICE CKS: Osteoporosis - Prevention of Fragility Fractures

NICE guideline CG146: Osteoporosis: Assessing the Risk of Fragility Fracture

NOGG Clinical Guideline for the Prevention and Treatment of Osteoporosis

SIGN 142: Management of Osteoporosis and the Prevention of Fragility Fractures

2020 Clinical Practice Guideline for the Diagnosis and Treatment of Postmenopausal Osteoporosis (AACE/ACE)

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update (Osteoporosis Canada)

Glucocorticoid-Induced Osteoporosis Clinical Practice Guidelines (American College of Rheumatology)

Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2

National Osteoporosis Guideline Group (NOGG) UK Clinical Guideline for the Prevention and Treatment of Osteoporosis

New European consensus on management of osteoporosis in advanced chronic kidney disease (IOF/ERA-EDTA, 2020)

New evidence-based guideline for the management of osteoporosis in men (International Osteoporosis Foundation, 2024)

Osteoporosis Prevention, Screening, and Diagnosis: ACOG Clinical Practice Guideline No. 1

Osteoporosis to Prevent Fractures: Screening Recommendation Statement (USPSTF, 2025)

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass: A Clinical Practice Guideline From the American College of Physicians (ACP) 2023

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline

Strong, Steady and Straight: UK Consensus Statement on Physical Activity and Exercise for Osteoporosis (National Osteoporosis Society, 2018)